Loading...
Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
BACKGROUND: Pirfenidone was approved by the European Medicines Agency and introduced in most European countries in 2011 for treatment of idiopathic pulmonary fibrosis (IPF). OBJECTIVE: To describe the national Danish experiences of pirfenidone treatment for IPF during 30 months with respect to targe...
Na minha lista:
| Udgivet i: | Eur Clin Respir J |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Co-Action Publishing
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5018656/ https://ncbi.nlm.nih.gov/pubmed/27616539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/ecrj.v3.32608 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|